Tibet Rhodiola Pharmaceutical Holding Co.,Ltd.’s Net Profit Rose 126.2% in First Half of 2023

Tibet Rhodiola Pharmaceutical Holding Co.,Ltd. (西藏诺迪康药业股份有限公司) (600211.SH) reported a net profit of 599.8 million yuan in the first half of 2023, up 126.2% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, up 35.5% year-on-year.

At the end of the reporting period, it had 4.8 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 28.1%.